Intralobar pulmonary sequestration presenting increased serum CA 19-9 and CA125

Internal Medicine

Volumn 41, Issue 10, 2002, Pages 875-878

  Yagyu, Hisanaga ^a   Adachi, Hideki ^a   Furukawa, Kinya ^a   Nakamura, Hiroyuki ^a   Sudoh, Akihiko ^a   Oh ishi, Shuuji ^a   Tsuchida, Fumihiro ^a   Kishi, Kouji ^a   Saitou, Makoto ^a   Matsuoka, Takeshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Course; Immunohistochemical staining; Mucus; Resection; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; TUMOR MARKER;

ADULT; ANGIOGRAPHY; ARTICLE; ASCENDING AORTA; BLOOD LEVEL; CASE REPORT; CILIATED EPITHELIUM; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG CYST; LUNG RESECTION; LUNG SEQUESTRATION; MALE; MUCUS; PULMONARY ARTERY MALFORMATION;

EID: 0036808645     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.875     Document Type: Article

References (15)

1. Pryce DM. Lower accessory pulmonary artery with intralobar sequestration of lung: A report of seven cases. J Pathol 58: 457-467, 1946.
2. Gupta MK, Arciaga R, Bocci L, Tubbs R, Bukowski R, Deodhar SD. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Cancer 56: 277-283, 1985.
3. Buccheri GF, Ferrigno D, Sartoris AM, Violante B, Vola F, Curcio A. Tumor markers in bronchogenic carcinoma. Cancer 60: 42-50, 1987.
4. Takayama S, Kataoka N, Usui Y, et al. CA19-9 in patients with benign pulmonary diseases. Nippon Kyobu Shikkann Gakkai Zasshi (The Japanese Journal of Thoracic Diseases) 28: 1326-1331, 1990 (in Japanese, Abstract in English).
5. Eerdekens MW, Nouwen EJ, Pollet DE, Briers TW, De Broe ME. Human placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases. Clin Chem 31: 687-690, 1985.
6. Ikezoe J, Murayama S, Goldwin JD, Done SJ, Verschakelen JA. Bronchopulmonary sequestration: CT assessment. Radiology 176: 375-379, 1990.
7. Savic B, Birtel FJ, Tholen W, Funke HD, Knoche R. Lung sequestration: report of seven cases and review of 540 published cases. Thorax 34: 96-101, 1979.
8. Sekiya M, Chiba A, Ienaga H, et al. Intralobar pulmonary sequestration presenting increased serum CEA, CA19-9, and CA125, and associated with asymptomatic pulmonary aspergillosis. Nihon Kokyuki Gakkai Zasshi (The Journal of the Japanese Respiratory Society) 37: 433-437, 1999 (in Japanese, Abstract in English).
9. Ishii H, Mukae H, Ihiboshi H, et al. Pulmonary sequestration associated with high levels of tumor markers in serum. Nippon Kyobu Shikkann Gakkai Zasshi (The Japanese Journal of Thoracic Diseases) 35: 1029-1033, 1997 (in Japanese, Abstract in English).
10. Nakamura H, Katsumi T, Nagata S, Saito M, Konaka C, Kato H. A resected case of intralobar pulmonary sequestration with increased serum tumor markers, CA19-9, CA125, and NCC-ST-439. Nippon Kyobu Shikkann Gakkai Zasshi (The Japanese Journal of Thoracic Diseases) 35: 1425-1429, 1997 (in Japanese, Abstract in English).
11. Nagaoka H, Taniguchi T, Iesato Y, et al. Pulmonary sequestration with the elevated serum value of CA19-9 -A case report- Nihon Rinsho Geka Igakukai Zasshi (Journal of Japanese Society for Clinical Surgery) 57: 571-574, 1996 (in Japanese, Abstract in English).
12. Uyama T, Monden Y, Harada K, et al. A case of intralobar pulmonary sequestration with calcification and elevated serum values of carcinoembryonic antigen and carbohydrate antigen 19-9. J Thorac Image 4: 74-76, 1989.
13. Shiota Y, Kitade M, Furuya K, Ueda N. A case of intralobar pulmonary sequestration with high serum CA19-9 levels. Acta Med Okayama 42: 297-300, 1988.
14. Nouwen EJ, Pollet DE, Eerdekens MW, Hendrix PG, Briers TM, DeBroe ME. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neo-plastic human lung. Cancer Res 46: 866-876, 1986.
15. Matsuoka Y, Endo K, Kawamura Y, et al. Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and Carcinoembryonic antigen. Cancer 65: 506-510, 1990.